Menu

Longevity Health Holdings, Inc. XAGE

Full chart Compare
Set alert

Price alert · XAGE

All alert types
0.10 USD 0.00 (+0.00%)

Nov 9, 2026, 12:16 PM EST

0.103 Day range 0.103
0.101 52-week range 0.65
YTD
-65.78%
1 year
-79.40%

Revenue & Expenses

Income Tax Benefit → Expenses: $97.28KExpenses → Selling, General & Admin: $3.90MExpenses → Research & Development: $1.05MExpenses → Other Operating Expenses: $83.49KExpenses → Interest Expense: $29.47KExpenses → Other Expenses: $5.44MGross Profit → Expenses: $43.96KRevenue → Gross Profit: $43.96KRevenue → Cost of Revenue: $6.36KNet Loss → Expenses: $10.37MIncome Tax Benefit$97.28KGross Profit$43.96KNet Loss$10.37MCost of Revenue$6.36KExpenses$10.51MSelling, General & Admin$3.90MResearch & Development$1.05MOther Operating Expenses$83.49KInterest Expense$29.47KOther Expenses$5.44MRevenue$50.32K

Latest period ending Dec 31, 2024 · select a line to chart its full history

XAGE annual income statement
Fiscal yearFY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
50.32K000
43.96K000
-5.00M-5.94M-5.51M-1.94M
-10.37M-15.45M-9.05M-6.48M
-14.70-43.80-164.00-8.70
XAGE annual balance sheet
Fiscal yearFY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
157.14K2.91M128.15K12.36K
1.47M63.95M1.75M1.56M
6.19M39.20M8.12M16.80M
638.99K2.14M3.74M9.69M
-4.71M24.75M-37.79M-29.58M
XAGE annual cash flow
Fiscal yearFY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-4.39M-8.35M-3.43M-1.18M
-748.80K-30.47K-7.16K-7.27K
2.38M11.16M3.55M1.20M
-2.76M2.78M115.79K11.21K